Bettina Cockroft
Director/Board Member chez ANNEXON, INC.
Fortune : - $ au 31/03/2024
Profil
Bettina M.
Cockroft is an Independent Director at Annexon, Inc. and CNS Pharmaceuticals, Inc. She is also a Director at Annexon Biosciences, Inc. Her former positions include Chief Medical Officer & Senior Vice President at Sangamo Therapeutics, Inc., Vice President-Clinical Research at Cytokinetics, Inc., and Chief Medical Officer at Auris Medical AG.
She holds a doctorate from the University of Genoa and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 | |
ANNEXON, INC.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Bettina Cockroft
| Sociétés | Poste | Début |
|---|---|---|
| ANNEXON, INC. | Director/Board Member | 20/01/2022 |
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 08/05/2023 |
| Annexon Biosciences, Inc. | Director/Board Member | - |
Anciens postes connus de Bettina Cockroft
| Sociétés | Poste | Fin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 16/05/2023 |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/09/2019 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | 01/09/2016 |
Formation de Bettina Cockroft
| University of Genoa | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| ANNEXON, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| CNS Pharmaceuticals, Inc. | |
| Annexon Biosciences, Inc. | |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
